People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Healthtech, Pharma, Other Technology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pearl Health, Inc. | — | Healthtech | Series C | $55.5M | $721.3M | 2022 |
| Affect Therapeutics, Inc. | — | Pharma | Series B | $24.6M | $232.4M | 2021 |
| Tempest, Inc. | — | Other Technology | Series A | $13.5M | $284.3M | 2017 |
| Conduce, Inc./DE/ | — | Other | Seed | $3.0M | $14.1M | 2024 |
| Ensage, Inc. | — | Other Health Care | Seed | $1.5M | $15.3M | 2022 |
Jeff DeFlavio at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff DeFlavio on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Ryan | 4 | 20 |
| Vineeta Agarwala | 1 | 8 |
| Stuart Peterson | 1 | 7 |
| Matthew Storeygard | 1 | 6 |
| Scott Kupor | 1 | 5 |
| Jeff Rinehart | 1 | 4 |
| Kristin Muhlner | 1 | 4 |
| Anarghya Vardhana | 1 | 3 |
| Eric Rosow | 1 | 2 |
| Holly Whitaker | 1 | 1 |
| Najib Jai | 1 | 1 |
| Michael Kopko | 1 | 1 |
| Doug Elwood | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.